VITALEX BIOSCIENCES, LLC
Vitalex Biosciences
Coto de Caza, United States · Founded 2015
- Headquarters
- Coto de Caza, California
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2G
- Website
- vitalexbiosciences.com
About
Vitalex Biosciences is a clinical-stage biotech spinoff from The Lundquist Institute at Harbor-UCLA developing immunotherapies and diagnostics for life-threatening fungal infections. Their lead program VXV-01 is a first-in-class monoclonal antibody targeting mucormycosis. In 2025, Vitalex and partner Appili Therapeutics were awarded a NIAID contract valued at up to $40 million.
Summary
VITALEX BIOSCIENCES, LLC is a Biotech company based in Coto de Caza, United States, founded in 2015.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vitalex-biosciences-llc"><img src="https://indexed.vc/api/badge/company/vitalex-biosciences-llc" alt="VITALEX BIOSCIENCES, LLC on Indexed.vc" width="260" height="76" /></a>